This study aims to understand how much kidney function improves after a simultaneous liver-kidney (SLK) transplant. Researchers are looking for people aged 18 or older who are listed for both a liver and kidney transplant, have two native kidneys, and are not on dialysis. You would have an estimated kidney function (eGFR) between 25 and 40. The study involves a special nuclear medicine scan called a Mercaptoacetyltriglycine 3 (Mag 3) scan, which uses a small amount of radiation, before and after your transplant. The goal is to find ways to predict who will have the best recovery of their native kidney function after an SLK transplant. This is an observational study with a planned enrollment of 15 participants, and its current status is unclear.

Study design

This is a pilot observational study that will follow participants over time. It plans to include 15 participants.

What's involved

You would have a Mag 3 nuclear medicine scan before and after your transplant. Data will be collected on your demographics and body mass index (BMI).

Compensation

Not stated in the trial record.

Follow-up

Your kidney function will be measured for up to 100 weeks after the transplant.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.